Hepatic and renal toxicities of indomethacin acid, salt form and complexed forms with hydroxypropyl‐β‐cyclodextrin on Wistar rats after oral administration
暂无分享,去创建一个
I. Figueiredo | F. Veiga | M. Caramona | M. M. Castel-Branco | A. C. Ribeiro-Rama | Ana Cristina Ribeiro‐Rama | Maria Margarida Castel‐Branco | António M. Silvério Cabrita | Maria Margarida Caramona | A. Cabrita
[1] James Lyons-Weiler,et al. Hepatic Gene Expression Response to Acute Indomethacin Exposure , 2012, Molecular Diagnosis & Therapy.
[2] A. Cabrita,et al. Evaluation of gastric toxicity of indomethacin acid, salt form and complexed forms with hydroxypropyl‐β‐cyclodextrin on Wistar rats: histopathologic analysis , 2009, Fundamental & clinical pharmacology.
[3] Y. Ou,et al. Indomethacin causes renal epithelial cell injury involving Mcl-1 down-regulation. , 2009, Biochemical and biophysical research communications.
[4] J. Dahlstrom,et al. Renal Glomeruli and Tubular Injury Following Indomethacin, Ibuprofen, and Gentamicin Exposure in a Neonatal Rat Model , 2007, Pediatric Research.
[5] F. Veiga,et al. Complexos de inclusão de indometacina com hidroxipropil-beta-ciclodextrina: estudos de dissolução e coeficiente de partição , 2006 .
[6] F. Veiga,et al. Aspectos biofarmacêuticos da formulação de medicamentos para neonatos: fundamentos da complexação de indometacina com hidroxipropil-beta-ciclodextrina para tratamento oral do fechamento do canal arterial , 2005 .
[7] M. Skeljo,et al. Gastric mucosal damage induced by nonsalicylate nonsteroidal antiinflammatory drugs in rats is mediated systemically , 1993, Digestive Diseases and Sciences.
[8] O. Bulbena,et al. Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal antiinflammatory drugs , 1993, Digestive Diseases and Sciences.
[9] B. Müller,et al. Effect of Cyclodextrin Derivatives on Indomethacin Stability in Aqueous Solution , 1990, Pharmaceutical Research.
[10] G. Liversidge,et al. Influence of Indomethacin Amphoteric Gel on Gastric Ulcerogenicity and Absorption of Indomethacin in Rats , 2004, Pharmaceutical Research.
[11] J. George,et al. Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs , 2002, Seminars in liver disease.
[12] N. Kaplowitz. Biochemical and Cellular Mechanisms of Toxic Liver Injury , 2002, Seminars in liver disease.
[13] D. Richardson. A woman with an extremely premature newborn. , 2001, JAMA.
[14] L. Szente,et al. Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. , 2001, Journal of pharmaceutical sciences.
[15] V. Turjanmaa,et al. Renal follow up of premature infants with and without perinatal indomethacin exposure , 2001, Archives of disease in childhood. Fetal and neonatal edition.
[16] V. Fanos,et al. NSAID-Induced Nephrotoxicity from the Fetus to the Child , 2001, Drug Safety.
[17] C. Hammerman,et al. Comparative Tolerability of Pharmacological Treatments for Patent Ductus Arteriosus , 2001, Drug safety.
[18] J. Guignard,et al. The Renal Hemodynamic Effects of Ibuprofen in the Newborn Rabbit , 2000, Pediatric Research.
[19] P. Gøtzsche,et al. Non-steroidal anti-inflammatory drugs , 2000, BMJ : British Medical Journal.
[20] N. Kaplowitz. Mechanisms of liver cell injury. , 2000, Journal of hepatology.
[21] G. Bertini,et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. , 1999, The Journal of pediatrics.
[22] L. Brion,et al. Furosemide in indomethacin-treated infants – systematic review and meta-analysis , 1999, Pediatric nephrology (Berlin, West).
[23] A. Price,et al. Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine , 1997, Gut.
[24] G. Tortorolo,et al. Furosemide does not prevent indomethacin‐induced renal side effects in preterm infants , 1997, Clinical pharmacology and therapeutics.
[25] M. Hanano,et al. Relationship between pharmacokinetics and the analgesic effect of indomethacin in the rat. , 1997, Biological and Pharmaceutical Bulletin.
[26] P. Fowlie,et al. Prophylactic indomethacin: systematic review and meta-analysis. , 1996, Archives of disease in childhood. Fetal and neonatal edition.
[27] J. Johnston,et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.
[28] D. Duchěne,et al. In vivo evaluation of indomethacin/ cyclodextrin complexes gastrointestinal tolerance and dermal anti-inflammatory activity , 1994 .
[29] M. Iwaki,et al. Pharmacokinetics of indomethacin octyl ester (prodrug) and indomethacin produced from the prodrug. , 1994, Journal of pharmaceutical sciences.
[30] I. Krasna,et al. Allopurinol protects the bowel from necrosis caused by indomethacin and temporary intestinal ischemia in mice. , 1993, Journal of pediatric surgery.
[31] H. Fessi,et al. Indomethacin-loaded poly (d,l-lactide) nanocapsules protection from gastrointestinal ulcerations and anti-inflammatory activity evaluation in rats , 1993 .
[32] D Wouessidjewe,et al. High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex. , 1990, Journal of pharmaceutical sciences.
[33] H. Fessi,et al. Rôle protecteur des nanocapsules vis-à-vis des lésions de la muqueuse gastrique produites par lindométacine chez le rat à pylore lié , 1989 .
[34] M. Cappell,et al. Indomethacin-associated cholestasis. , 1988, Journal of Clinical Gastroenterology.
[35] R. Day,et al. Non-steroidal anti-inflammatory drugs , 2019, Reactions Weekly.
[36] M. Black,et al. Drug induced liver disease. , 1983, Postgraduate medical journal.
[37] J. Loewenthal,et al. Chronic gastric ulcer in the rat produced by wounding at the fundo-antral junction. , 1976, Gastroenterology.
[38] F. Kuehl,et al. THE METABOLITES OF INDOMETHACIN, A NEW ANTI-INFLAMMATORY DRUG. , 1964, The Journal of pharmacology and experimental therapeutics.